Recent advances in the bench-to-bedside translation of cancer nanomedicines
aDepartment of Hepatobiliary Cancer, Liver Cancer Center, Tianjin Medical University Cancer Institute & Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin’s Clinical Research Center for Cancer, Tianjin 300060, China
bDepartment of Hepatobiliary and Pancreatic Oncology, Tianjin Cancer Hospital Airport Hospital, National Clinical Research Center for Cancer, Tianjin 300308, China
cDepartment of Biochemistry and Molecular Biology, Tulane University School of Medicine, New Orleans, LA 70112, USA
* Corresponding author.
收起